Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Yugal Sikri
|
| gptkbp:country |
gptkb:India
|
| gptkbp:formerName |
Searle (India) Ltd.
|
| gptkbp:foundedYear |
1993
|
| gptkbp:headquartersLocation |
gptkb:Mumbai
|
| https://www.w3.org/2000/01/rdf-schema#label |
RPG Life Sciences
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:listedOn |
gptkb:Bombay_Stock_Exchange
gptkb:National_Stock_Exchange_of_India |
| gptkbp:numberOfEmployees |
500-1000
|
| gptkbp:parentCompany |
gptkb:RPG_Group
|
| gptkbp:products |
gptkb:biotechnology
active pharmaceutical ingredients formulations |
| gptkbp:revenue |
INR 400+ crore (approx, 2023)
|
| gptkbp:stockSymbol |
RPGLIFE
|
| gptkbp:website |
https://www.rpglifesciences.com/
|
| gptkbp:bfsParent |
gptkb:RPG_Group
|
| gptkbp:bfsLayer |
6
|